Privi Speciality Chemicals Limited (PRIVISCL)

Loading page…

Privi Speciality Chemicals Limited (PRIVISCL) · mywealthgrid

About

Privi Speciality Chemicals Limited manufactures specialty chemicals. With quarterly revenue of ₹600–720 Cr and market cap of ₹13,615 Cr, the company demonstrates consistent profitability. Operating margins of 25.21% and ROE of 25.18% reflect strong capital efficiency.

Face value: ₹10

Market cap

₹13,970 Cr

P/E

40.8×

P/B

9.9×

Dividend yield

0.3%

ROE

25.2%

ROCE

27.7%

Debt / equity

0.72

OPM

25.2%

EPS (TTM)

₹87.6

Book value

₹361.6

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

High valuation leaves limited upside: PE of 39.81 after 40.74% one-year return, with stock at ₹3,482 near the 52-week high of ₹3,751
Revenue growth trajectory unclear: quarterly revenue ranged ₹572–721 Cr across recent quarters without clear expansion trend
Operating margin volatility: OPM swung 22.85–28.09% across quarters; verify input cost exposure and customer price pass-through
Thin institutional backing: FII at 1.94% and DII at 10.08% suggest limited institutional support; verify liquidity and holding stability

Generated analysis · source review pending

Growth drivers

Quarterly net profit of ₹74–102 Cr provides cash for reinvestment and debt service
Operating margin of 25.21% and ROE of 25.18% support capital-efficient expansion
Indian specialty chemicals market growth — verify sector CAGR, company's addressable market, and market penetration potential
Regulatory or demand tailwinds in specialty chemicals for pharma, food, cosmetics — verify end-market exposure and company relevance

Generated analysis · source review pending

2,528 historical price candles were omitted because the exchange source has not been verified.

₹3,573.0-0.9%1Y

Quick read

rule-based

Pros

+Strong return on equity of 18.1% (3-yr avg)
+High return on capital employed of 22.1%
+Healthy operating margin of 25.2%
+Profit CAGR of 16.7% over the last 5 years
+High promoter holding of 60.6% with no pledge

Cons

−Trading at 9.9× book value
−Low dividend payout of 11.4% of profit
−Promoter holding fell 9.3 pts over the last year

Research score

Structured signal from quality, growth, valuation and momentum.

60/100

Business quality: 65
Growth

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Part ofNIFTY SMALLCAP 250 NIFTY MIDSMALLCAP 400 NIFTY 500 NIFTY TOTAL MARKET

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Gujarat Fluorochemicals LimitedFLUOROCHEMFLUOROCHEM	₹47,713 Cr	₹49,912 Cr	₹5,303 Cr	₹1,375 Cr	25.8%	₹615 Cr	11.5%	11.1%	7.6%	401
Navin Fluorine International LimitedNAVINFLUORNAVINFLUOR	₹41,740 Cr	₹42,967 Cr	₹3,634 Cr	₹1,232 Cr	32.6%	₹790 Cr	20%	21.6%	20.1%	61
Aether Industries LimitedAETHERAETHER	₹22,161 Cr	₹22,603 Cr	₹1,224 Cr	₹384 Cr	31.3%	₹235 Cr	19.8%	13.2%	9.4%	330
Atul LimitedATULATUL	₹17,231 Cr	₹17,411 Cr	₹6,643 Cr	₹1,189 Cr	16.4%	₹704 Cr	11%	14.1%	11.5%	70
Aarti Industries LimitedAARTIINDAARTIIND	₹16,869 Cr	₹21,790 Cr	₹9,012 Cr	₹1,337 Cr	14.1%	₹531 Cr	5.1%	8.8%	7.3%	54
Fine Organic Industries LimitedFINEORGFINEORG	₹15,752 Cr	₹15,797 Cr	₹2,472 Cr	₹535 Cr	20.4%	₹438 Cr	17.6%	21.6%	16.8%	113
Basf India LimitedBASFBASF	₹14,796 Cr	₹14,796 Cr	₹16,177 Cr	₹952 Cr	4.4%	₹643 Cr	2.8%	14%	11.1%	40
Privi Speciality Chemicals LimitedPRIVISCLPRIVISCL	₹13,970 Cr	₹14,980 Cr	₹2,671 Cr	₹666 Cr	25.2%	₹342 Cr	12.4%	27.7%	25.2%	158
Sudeep Pharma LimitedSUDEEPPHRMSUDEEPPHRM	₹13,546 Cr	₹13,694 Cr	₹676 Cr	₹233 Cr	34.6%	₹133 Cr	27.1%	31.1%	25.2%	366
Anupam Rasayan India LimitedANURASANURAS	₹13,243 Cr	₹15,058 Cr	₹2,535 Cr	₹563 Cr	22.2%	₹175 Cr	9.4%	9.1%	5.5%	377
Vinati Organics LimitedVINATIORGAVINATIORGA	₹12,528 Cr	₹12,528 Cr	₹2,381 Cr	₹665 Cr	29.4%	₹448 Cr	19.9%	18.8%	14.9%	152
Elantas Beck India LimitedELANTASELANTAS	₹10,644 Cr	₹10,644 Cr	₹778 Cr	₹147 Cr	20.3%	₹136 Cr	17.4%	20.6%	15.8%	70

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1,040	1,341	1,631	1,277	1,404	1,608	1,752	2,101	2,564
COGS	663	827	1,008	751	831	961	1,009	1,131	1,317
Gross profit	377	514	623	525	573	647	743	970	1,247
	247	301	355	318	379	461	418	516	600
	130	213	268	208	194	186	325	454	646
OPM %	12.5%	15.9%	16.4%	16.3%	13.8%	11.6%	18.5%	21.6%	25.2%
Depreciation	43	47	63	71	75	108	123	132	144
Interest	24	29	41	21	24	68	98	88	82
	16	15	67	43	38	21	26	21	19
Profit before tax	79	152	231	158	133	31	130	255	440
Tax	26	57	55	41	35	10	34	70	123
Tax %	32.5%	37.8%	23.8%	26.1%	26.6%	31.5%	26.5%	27.4%	28%
	53	94	176	117	97	21	95	185	317
PAT margin %	5.1%	7%	10.8%	9.2%	6.9%	1.3%	5.5%	8.8%	12.4%
EPS (₹)	13.7	24.1	45.1	0	24.9	5.5	24.4	47.9	83.9
EPS adjusted (₹)	—	—	45.1	37.4	24.9	6.3	24.4	47.3	81.1
	11%	10.4%	3.3%	—	8%	0%	8.2%	10.4%	11.9%
Annual report	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	39	39	39	39	39	39	39
Reserves	573	683	773	790	885	1,064	1,373
Minority interest	—	—	7	6	17	14	28
	481	496	834	1,061	981	1,123	1,010
	291	322	523	495	421	550	719
Total equity & liabilities	1,384	1,540	2,176	2,391	2,343	2,791	3,170
	566	567	651	1,017	1,034	1,156	1,169
CWIP	30	174	364	95	89	127	298
Investments	1	0	12	7	40	8	55
	786	798	1,150	1,273	1,179	1,499	1,649
Total assets	1,384	1,540	2,176	2,391	2,343	2,791	3,170

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs.

Source XBRL ↗

Latest reported period · 31 Mar 2020 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities
Aroma Chemicals	1,324.11	160.38	—	750.77
Oleo Chemicals and Intermdiate Neutraceuticals	306.49	44.87	—	79.53

SegmentFigure

Aroma Chemicals · revenue

₹ crore by fiscal year

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	38.3%	38.2%	41.2%	40.8%

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	74.05%	74.05%	74.05%	74.05%	74.05%	74.05%	74.05%	69.89%	69.89%	60.6%	60.6%	60.6%
	0.97%	0.96%	0.62%	0.48%	0.43%	0.48%	0.4%	1.47%	1.33%	1.64%	1.38%	1.94%
	3.37%	3.4%	3.37%	2.84%	2.5%	2.09%	1.95%	3.9%	4.55%	10.24%	10.67%	10.08%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	21.61%	21.59%	21.96%	22.63%	23.02%	23.38%	23.6%	24.74%	24.23%	27.52%	27.35%	27.38%
No. of shareholders	—	—	—	—	—	—	—	—	28,203	32,016	34,415	44,875

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

across 5 fund houses

Held by these funds

8.04%

of the company's equity

All mutual funds

8.55%

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

9 schemes · 5 fund houses

		Shares
Smallcap Fund	SBI Mutual Fund	19 L	660.08	1.55%	4.859%	-0
Children's Fund - Investment Plan (Erstwhile known as SBI Magnum Children's Benefit Fund- IP)	SBI Mutual Fund	5.74 L	199.46	2.57%	1.468%	-37,220
Multi Asset Allocation Fund	SBI Mutual Fund	3.53 L	122.47	0.58%	0.902%	-97,155
MNC Fund	SBI Mutual Fund	1.8 L	62.53	0.93%	0.46%	-11,741
TRUSTMF Small Cap Fund	Trust Mutual Fund	97,794	33.97	0.99%	0.25%	-0
(Investment Manager for Motilal Oswal Mutual Fund)	Motilal Oswal Mutual Fund	34,751	12.07	0.48%	0.089%	-761
MULTI CAP FUND	Samco Mutual Fund	3,020	1.05	0.46%	0.008%	-133
IB18-Groww Nifty Total Market Index Fund	Groww Mutual Fund	237	0.08	0.02%	0.001%	+1

1–8 of 9

1 / 2

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

16

Final dividend31 Jul 2026 · ex-date₹10
Final dividend24 Jul 2025 · ex-date₹5
Final dividend24 Jul 2024 · ex-date₹2
Final dividend20 Sept 2022 · ex-date₹2
Final dividend17 Aug 2021 · ex-date₹2
Dividend dividend26 Oct 2020 · ex-date₹1.5
Dividend dividend1 Aug 2019 · ex-date₹2.5
Dividend dividend2 Aug 2018 · ex-date₹1.5
Dividend dividend3 Aug 2017 · ex-date₹1
Dividend dividend1 Sept 2016 · ex-date₹2.5
Dividend dividend19 Jun 2015 · ex-date₹2.5
Dividend dividend29 May 2014 · ex-date₹1.5
Dividend dividend29 May 2013 · ex-date₹1
Dividend dividend12 Jul 2012 · ex-date₹1
Dividend dividend21 Jul 2011 · ex-date₹1
Dividend dividend13 Sept 2007 · ex-date₹0

1

Board meeting to consider results30 Jul 2026

3

Bonus 1:109 Jul 2014 · ex-date
Bonus 1:103 Jul 2013 · ex-date
Bonus 1:512 Jul 2012 · ex-date

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

18 announcementsExport CSV

17 Sept 2026, 2:33 pmCompany Update

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Analyst / Investor Meet PDF

Loading announcements…

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	38.3%	38.2%	41.2%	40.8%

11 deals · 19 Jun 2025 – 31 Dec 2025

Date	Client	Type	Venue	Side	Quantity	Price	Value
31 Dec 2025	VIVIRA INVESTMENT AND TRADING PVT LTD	Bulk	NSE	Sell	36,28,627	₹2,838.00	₹1,029.80 Cr
31 Dec 2025	SBI MUTUAL FUND	Bulk	NSE	Buy	22,40,000	₹2,833.96	₹634.81 Cr
31 Dec 2025	BHAUMIKBHAI KIRITBHAI DOSHI	Bulk	NSE	Buy	2,80,620	₹2,836.91	₹79.61 Cr
31 Dec 2025	BHAUMIKBHAI KIRITBHAI DOSHI	Bulk	NSE	Sell	92,421	₹2,793.99	₹25.82 Cr
3 Jul 2025	RAJESH HARICHANDRA BUDHRANI	Bulk	NSE	Sell	2,00,000	₹2,261.50	₹45.23 Cr
19 Jun 2025	SBI MUTUAL FUND	Bulk	NSE	Buy	12,22,721	₹2,055.00	₹251.27 Cr
19 Jun 2025	BHAKTAVATSALA RAO DOPPALAPUDI	Bulk	NSE	Sell	7,00,000	₹2,055.00	₹143.85 Cr
19 Jun 2025	VINAYKUMAR DOPPALAPUDI RAO	Bulk	NSE	Sell	3,30,000	₹2,087.70	₹68.89 Cr
19 Jun 2025	VIJAY KUMAR DOPPALAPUDI	Bulk	NSE	Sell	3,20,000	₹2,055.00	₹65.76 Cr
19 Jun 2025	SBI FUNDS MANAGEMENT LIMITED	Bulk	NSE	Buy	2,80,000	₹2,055.00	₹57.54 Cr

1–10 of 11

1 / 2

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Date	Category	Subject	Filing
17 Sept 2026, 2:33 pm	Company Update Analyst / Investor Meet	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation	PDF
11 Aug 2026, 4:13 pm	Company Update Analyst / Investor Meet	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation	PDF
10 Aug 2026, 6:09 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report	PDF
7 Aug 2026, 6:01 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Outcome of AGM	PDF
3 Aug 2026, 5:27 pm	Company Update Earnings Call Transcript	Announcement under Regulation 30 (LODR)-Earnings Call Transcript	PDF
31 Jul 2026, 5:50 pm	Company Update Analyst / Investor Meet	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome	PDF
30 Jul 2026, 5:38 pm	Company Update Investor Presentation	Announcement under Regulation 30 (LODR)-Investor Presentation	PDF
30 Jul 2026, 1:26 pm	Result Financial Results	Unaudited Financial Results For The Quarter Ended June 30,2026.	PDF

₹ Cr	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	216	172	5	49	354	281	550
	-174	-242	-320	-133	-180	-294	-358
	29	0	333	72	-171	39	-198
Net cash flow	72	-69	17	-12	4	26	-6
Free cash flow	46	-71	-304	-91	204	-18	230
CFO / Operating profit %	80.6%	82.9%	2.5%	26.2%	109.1%	62%	85.1%

Leverage
Current ratio	—	1.42	1.54	1.13	1.09	1.27	1.24	1.46

Privi Speciality Chemicals Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Segment results

Aroma Chemicals · revenue

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

16

1

3

Announcements

16

1

3

Not in the F&O segment

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Segment results

Aroma Chemicals · revenue

Compounded sales growth

Compounded profit growth

Return on equity

Return ratios
Return on assets %	—	12.7%	7.6%	4.5%	0.9%	4.1%	6.6%	10%

Working capital
Receivable days	—	51	68	69	67	72	68	75

Privi Speciality Chemicals Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Segment results

Aroma Chemicals · revenue

Ratios

Ratio timeline

Shareholding

Quarterly record

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

Dividends16

Board meetings1

Bonus issues3

Announcements

Dividends16

Board meetings1

Bonus issues3

Not in the F&O segment

Announcements

Ratio timeline

Quarterly record

Annual reports

Credit ratings

Investor Presentation and earnings call

Bulk & block deals

Board and management

Profit & loss

Balance sheet

Segment results

Aroma Chemicals · revenue

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

16

1

3

16

1

3